David Abrams's NUVB Position Overview
David Abrams (via Abrams Capital Management, L.P.) currently holds 1.27 M shares of Nuvation Bio Inc. (NUVB) worth $5.45 M, representing 0.12% of the portfolio. First purchased in 2021-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, David Abrams has maintained a strategic position in NUVB, demonstrating sustained confidence in this investment. Largest reduction occurred in Q1 2026, reducing 2.54 M shares.
Analysis based on 13F filings available since 2013 Q2
David Abrams's Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by David Abrams
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -2.54 M | Reduce 66.67% | 1.27 M | $4.29 |
| Q1 2021 | +3.81 M | New Buy | 3.81 M | $8.92 |
David Abrams's Nuvation Bio Investment FAQs
David Abrams first purchased Nuvation Bio Inc. (NUVB) in Q1 2021, acquiring 3,811,513 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
David Abrams has held Nuvation Bio Inc. (NUVB) for 21 quarters since Q1 2021.
David Abrams's largest addition to Nuvation Bio Inc. (NUVB) was in Q1 2021, adding 3,811,513 shares worth $33.99 M.
According to the latest 13F filing for Q1 2026, David Abrams's firm, Abrams Capital Management, L.P., owns 1,270,504 shares of Nuvation Bio Inc. (NUVB), valued at approximately $5.45 M.
As of the Q1 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.12% of David Abrams's publicly disclosed stock portfolio, making it one of their key holdings.
David Abrams's peak holding in Nuvation Bio Inc. (NUVB) was 3,811,513 shares, as reported at the end of Q1 2021.